Great Basin Scientific (GBSN) Reports Q2 Loss of $4.10/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Great Basin Reports Second Quarter 2016 Results
August 11, 2016 4:02 PM EDTCompany sees 38.7% year-over-year revenue growth; continues strong progress toward customer acquisition, assay placement and product development targets
SALT LAKE CITY--(BUSINESS WIRE)-- Great Basin Scientific, Inc. (NASDAQ: GBSN), a molecular diagnostic testing company, today reported financial results for the second quarter ended June 30, 2016.
Second Quarter 2016 Financial Results and Business Highlights
Revenue increased 38.7% to $728,957 compared with a year ago Total installed customer base up 126.1% over last year to 260 Assay adoption rate (assays placed) up 18.2% over last year... More